Research Study: Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
Summary: According to a new study published by the Lancet, two major medications used for smoking cessation do not appear to increase the risk of mental health disorders such as depression, anxiety and suicidal thoughts.